Your browser doesn't support javascript.
loading
Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy.
Li, Gaopeng; Choi, Jae Eun; Kryczek, Ilona; Sun, Yilun; Liao, Peng; Li, Shasha; Wei, Shuang; Grove, Sara; Vatan, Linda; Nelson, Reagan; Schaefer, Grace; Allen, Steven G; Sankar, Kamya; Fecher, Leslie A; Mendiratta-Lala, Mishal; Frankel, Timothy L; Qin, Angel; Waninger, Jessica J; Tezel, Alangoya; Alva, Ajjai; Lao, Christopher D; Ramnath, Nithya; Cieslik, Marcin; Harms, Paul W; Green, Michael D; Chinnaiyan, Arul M; Zou, Weiping.
Affiliation
  • Li G; Department of Surgery, University of Michigan, Ann Arbor, MI, USA; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
  • Choi JE; Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Kryczek I; Department of Surgery, University of Michigan, Ann Arbor, MI, USA; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
  • Sun Y; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
  • Liao P; Department of Surgery, University of Michigan, Ann Arbor, MI, USA; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
  • Li S; Department of Surgery, University of Michigan, Ann Arbor, MI, USA; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
  • Wei S; Department of Surgery, University of Michigan, Ann Arbor, MI, USA; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
  • Grove S; Department of Surgery, University of Michigan, Ann Arbor, MI, USA; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
  • Vatan L; Department of Surgery, University of Michigan, Ann Arbor, MI, USA; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
  • Nelson R; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Schaefer G; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Allen SG; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Sankar K; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Fecher LA; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Mendiratta-Lala M; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Frankel TL; Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
  • Qin A; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Waninger JJ; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Tezel A; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Alva A; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Lao CD; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Ramnath N; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA; Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA.
  • Cieslik M; Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
  • Harms PW; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Green MD; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA; Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA; Graduate Program in Immunology
  • Chinnaiyan AM; Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA.
  • Zou W; Department of Surgery, University of Michigan, Ann Arbor, MI, USA; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Graduate Program in Immunology, Univer
Cancer Cell ; 41(2): 304-322.e7, 2023 02 13.
Article in En | MEDLINE | ID: mdl-36638784
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Beta Catenin / Neoplasms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Beta Catenin / Neoplasms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: United States